Our research focuses on some of the most challenging nosocomial pathogens, including the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), as well as the widely prevalent Escherichia coli. These organisms are not only key drivers of hospital-acquired infections but also exemplify the complexities of antimicrobial resistance and disease progression.

By investigating their biology, pathogenicity, and resistance mechanisms, we aim to advance our understanding of these critical pathogens. This work has the potential to inform the development of innovative therapeutic strategies and redefine approaches to managing and treating multidrug-resistant infections.